Skip to main content

"Half-Dose Trial Finding Intriguing Result": Oxford Vaccine Chief

The Oxford/AstraZeneca COVID-19 vaccine candidate's late-stage trial results are "intriguing" and more work needs to be done on the finding that an initial half dose of the shot offers more...

https://ift.tt/eA8V8J

Comments

Popular posts from this blog